SEVERE ASTHMA: PHENOTYPES AND ROLE OF SMALL AIRWAYS-Reference-Cited by-同舟云学术

SEVERE ASTHMA: PHENOTYPES AND ROLE OF SMALL AIRWAYS

Published:2012-12-15 Issue:6 Volume:9 Page:49-54
ISSN:2686-682X
Container-title:Russian Journal of Allergy
language:
Short-container-title:Russian Journal of Allergy

Author:

Fassakhov R S

Abstract

The role of small airways in severe asthma is discussed. The involvement of small airways in the inflammatory process increases the importance of the value delivery systems for effective anti-inflammatory therapy. Extrafine aerosol beclomethasone dipropionate / formoterol (Foster) delivers the drug in the small bronchi significantly improving patient outcomes.

Publisher

Farmarus Print Media

Reference21 articles.

1. W Busse. Difficult to treat asthma: how serious is the problem and what the issues? Difficult-to-Treat Severe Asthma Edited by K.F. Chung, E.H. Bel and S.E. Wenzel. European Respiratory Society Monograph. 2011, v 51, p. 1-15.

2. Li X., Howard T.D., Ampleford E.J. et al. Genome-wide association study of asthma severity using proportional odds model identifies TMEM 154. Am. Rev. Resp. Crit. Care Med. 2010, v. 181, A37287.

3. Bousquet J., Mantzouranis E., Cruz A. et al. Uniform definition of asthma severity, control, and exacerbations: Document presented for the World Health Organization Consultation on Severe Asthma. Workshop summary J. Allergy Clin. Immunol. 2010, v. 126, p. 926-938.

4. Humbert M., Beasley R., Ayres J. et al. Benefits of omalizumab as add-on therapy in patients with severe persistent asthma who are inadequately controlled despite best available therapy (GINA 2002 step 4 treatment): INNOVATE. Allergy. 2005, v. 60 (3), p. 309-316.

5. Chipps B.E., Figliomeni M., Spector S. Omalizumab: An update on efficacy and safety in moderate-to-severe allergic asthma. Allergy Asthma Proc. 2012, v. 33 (5), p. 377-385.